Accueil COVID et coagulation

COVID et coagulation

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up (Journal Pre-proof)

Fibrinolysis Shutdown Correlates to COVID-19 Associated Thromboembolic Events

———————————————————————————————————————————

FICHE CONDUITE THERAPEUTIQUE du GIHP et du GFHT

Traitement anticoagulant pour la prévention du risque thromboembolique lors d’une infection par le COVID-19 et surveillance de l’hémostase

Sophie Susen, Charles Ambroise Tacquard, Alexandre Godon, Alexandre Mansour, Delphine Garrigue, Philippe Nguyen, Anne Godier, Pierre Albaladejo, Yves Gruel,
pdf : COVID-19 GIHP-GFHT-2 avril_V1 final

Tableau de propositions

pdf : Tableau_proposition GIHP 2 avril_Final V1

———————————————————————————————————————————

Quelle la gestion de la prophylaxie antithrombotique chez les patients Covid-19 ?